vs
Side-by-side financial comparison of IDACORP INC (IDA) and QuidelOrtho Corp (QDEL). Click either name above to swap in a different company.
QuidelOrtho Corp is the larger business by last-quarter revenue ($699.9M vs $360.1M, roughly 1.9× IDACORP INC). IDACORP INC runs the higher net margin — 12.1% vs -104.7%, a 116.8% gap on every dollar of revenue. On growth, QuidelOrtho Corp posted the faster year-over-year revenue change (-3.7% vs -4.2%). QuidelOrtho Corp produced more free cash flow last quarter ($-94.7M vs $-216.2M). Over the past eight quarters, QuidelOrtho Corp's revenue compounded faster (-2.9% CAGR vs -7.2%).
IDACORP, Inc is an electricity holding company, incorporated in Idaho with headquarters in Boise. It comprises Idaho Power Company, IDACORP Financial and Ida-West Energy. It was formed on October 1, 1998.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
IDA vs QDEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $360.1M | $699.9M |
| Net Profit | $43.6M | $-733.0M |
| Gross Margin | — | — |
| Operating Margin | 14.9% | -100.7% |
| Net Margin | 12.1% | -104.7% |
| Revenue YoY | -4.2% | -3.7% |
| Net Profit YoY | 15.1% | -3583.4% |
| EPS (diluted) | $0.78 | $-10.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $360.1M | — | ||
| Q3 25 | $526.4M | $699.9M | ||
| Q2 25 | $449.3M | $613.9M | ||
| Q1 25 | $411.1M | $692.8M | ||
| Q4 24 | $375.9M | $707.8M | ||
| Q3 24 | $532.5M | $727.1M | ||
| Q2 24 | $442.6M | $637.0M | ||
| Q1 24 | $417.9M | $711.0M |
| Q4 25 | $43.6M | — | ||
| Q3 25 | $124.4M | $-733.0M | ||
| Q2 25 | $95.8M | $-255.4M | ||
| Q1 25 | $59.6M | $-12.7M | ||
| Q4 24 | $37.9M | $-178.4M | ||
| Q3 24 | $113.6M | $-19.9M | ||
| Q2 24 | $89.5M | $-147.7M | ||
| Q1 24 | $48.2M | $-1.7B |
| Q4 25 | 14.9% | — | ||
| Q3 25 | 27.5% | -100.7% | ||
| Q2 25 | 22.4% | -29.4% | ||
| Q1 25 | 13.4% | 4.7% | ||
| Q4 24 | 11.0% | -14.2% | ||
| Q3 24 | 25.1% | 2.1% | ||
| Q2 24 | 23.3% | -18.4% | ||
| Q1 24 | 11.9% | -247.3% |
| Q4 25 | 12.1% | — | ||
| Q3 25 | 23.6% | -104.7% | ||
| Q2 25 | 21.3% | -41.6% | ||
| Q1 25 | 14.5% | -1.8% | ||
| Q4 24 | 10.1% | -25.2% | ||
| Q3 24 | 21.3% | -2.7% | ||
| Q2 24 | 20.2% | -23.2% | ||
| Q1 24 | 11.5% | -239.9% |
| Q4 25 | $0.78 | — | ||
| Q3 25 | $2.26 | $-10.78 | ||
| Q2 25 | $1.76 | $-3.77 | ||
| Q1 25 | $1.10 | $-0.19 | ||
| Q4 24 | $0.72 | $-2.54 | ||
| Q3 24 | $2.12 | $-0.30 | ||
| Q2 24 | $1.71 | $-2.20 | ||
| Q1 24 | $0.95 | $-25.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.7M | $98.1M |
| Total DebtLower is stronger | $3.3B | $2.5B |
| Stockholders' EquityBook value | $3.6B | $2.0B |
| Total Assets | $10.2B | $5.7B |
| Debt / EquityLower = less leverage | 0.93× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.7M | — | ||
| Q3 25 | $333.2M | $98.1M | ||
| Q2 25 | $474.5M | $151.7M | ||
| Q1 25 | $634.5M | $127.1M | ||
| Q4 24 | $368.9M | $98.3M | ||
| Q3 24 | $427.9M | $143.7M | ||
| Q2 24 | $169.6M | $107.0M | ||
| Q1 24 | $157.6M | $78.5M |
| Q4 25 | $3.3B | — | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $3.1B | $2.1B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $3.6B | — | ||
| Q3 25 | $3.5B | $2.0B | ||
| Q2 25 | $3.4B | $2.8B | ||
| Q1 25 | $3.3B | $3.0B | ||
| Q4 24 | $3.3B | $3.0B | ||
| Q3 24 | $3.3B | $3.2B | ||
| Q2 24 | $3.2B | $3.2B | ||
| Q1 24 | $2.9B | $3.3B |
| Q4 25 | $10.2B | — | ||
| Q3 25 | $10.1B | $5.7B | ||
| Q2 25 | $9.9B | $6.4B | ||
| Q1 25 | $9.6B | $6.5B | ||
| Q4 24 | $9.2B | $6.4B | ||
| Q3 24 | $9.1B | $6.8B | ||
| Q2 24 | $8.7B | $6.7B | ||
| Q1 24 | $8.3B | $6.7B |
| Q4 25 | 0.93× | — | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 0.74× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | 0.92× | 0.72× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $137.8M | $-45.5M |
| Free Cash FlowOCF − Capex | $-216.2M | $-94.7M |
| FCF MarginFCF / Revenue | -60.0% | -13.5% |
| Capex IntensityCapex / Revenue | 98.3% | 7.0% |
| Cash ConversionOCF / Net Profit | 3.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-577.5M | $-153.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $137.8M | — | ||
| Q3 25 | $162.8M | $-45.5M | ||
| Q2 25 | $176.9M | $-46.8M | ||
| Q1 25 | $124.3M | $65.6M | ||
| Q4 24 | $136.4M | $63.7M | ||
| Q3 24 | $201.9M | $117.9M | ||
| Q2 24 | $146.4M | $-97.9M | ||
| Q1 24 | $109.7M | $-700.0K |
| Q4 25 | $-216.2M | — | ||
| Q3 25 | $-127.9M | $-94.7M | ||
| Q2 25 | $-156.4M | $-84.3M | ||
| Q1 25 | $-77.0M | $9.4M | ||
| Q4 24 | $-48.9M | $16.5M | ||
| Q3 24 | $-16.1M | $71.4M | ||
| Q2 24 | $-199.6M | $-133.2M | ||
| Q1 24 | $-150.3M | $-66.8M |
| Q4 25 | -60.0% | — | ||
| Q3 25 | -24.3% | -13.5% | ||
| Q2 25 | -34.8% | -13.7% | ||
| Q1 25 | -18.7% | 1.4% | ||
| Q4 24 | -13.0% | 2.3% | ||
| Q3 24 | -3.0% | 9.8% | ||
| Q2 24 | -45.1% | -20.9% | ||
| Q1 24 | -36.0% | -9.4% |
| Q4 25 | 98.3% | — | ||
| Q3 25 | 55.2% | 7.0% | ||
| Q2 25 | 74.2% | 6.1% | ||
| Q1 25 | 49.0% | 8.1% | ||
| Q4 24 | 49.3% | 6.7% | ||
| Q3 24 | 41.0% | 6.4% | ||
| Q2 24 | 78.2% | 5.5% | ||
| Q1 24 | 62.2% | 9.3% |
| Q4 25 | 3.16× | — | ||
| Q3 25 | 1.31× | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 2.08× | — | ||
| Q4 24 | 3.60× | — | ||
| Q3 24 | 1.78× | — | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | 2.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDA
| Retailrevenues | $323.0M | 90% |
| Transmissionserviceswheeling | $18.6M | 5% |
| Energyefficiencyprogramrevenues | $11.7M | 3% |
| Wholesaleenergysales | $10.5M | 3% |
| Otherrevenues | $9.5M | 3% |
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
